Neurocrine Biosciences Advances with Promising INGREZZA Data and Strong Financial Outlook
Neurocrine Biosciences, a biopharmaceutical leader, is poised for future growth with a strong financial position, robust pipeline of treatments, and a proven track record of innovation.
2 minutes to read